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Abstract X-chromosome inactivation (XCI) results in
the differential marking of the active and inactive X with
epigenetic modiﬁcations including DNA methylation.
Consistent with the previous studies showing that CpG
island-containing promoters of genes subject to XCI are
approximately 50% methylated in females and unmethyl-
ated in males while genes which escape XCI are unme-
thylated in both sexes; our chromosome-wide (Methylated
DNA ImmunoPrecipitation) and promoter-targeted meth-
ylation analyses (Illumina Inﬁnium HumanMethylation27
array) showed the largest methylation difference
(D = 0.12, p\2.2 E-16) between male and female blood
at X-linked CpG islands promoters. We used the methyl-
ation differences between males and females to predict
XCI statuses in blood and found that 81% had the same
XCI status as previously determined using expression data.
Most genes (83%) showed the same XCI status across
tissues (blood, fetal: muscle, kidney and nerual); however,
the methylation of a subset of genes predicted different
XCI statuses in different tissues. Using previously pub-
lished expression data the effect of transcription on gene-
body methylation was investigated and while X-linked
introns of highly expressed genes were more methylated
than the introns of lowly expressed genes, exonic methyl-
ation did not differ based on expression level. We conclude
that the XCI status predicted using methylation of X-linked
promoters with CpG islands was usually the same as
determined by expression analysis and that 12% of
X-linked genes examined show tissue-speciﬁc XCI
whereby a gene has a different XCI status in at least one of
the four tissues examined.
Introduction
To achieve dosage compensation with 46,XY males,
46,XX mammalian females undergo X-chromosome inac-
tivation (XCI), which results in one inactive X chromo-
some (Xi) and one active X chromosome (Xa). Based
predominantly on studies using somatic cell hybrids the
majority of X-linked genes have been determined to be
subject to XCI and are only expressed from the Xa, while
approximately 15% of genes escape XCI and are expressed
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Genes which escape XCI are enriched in the more evolu-
tionarily recently diverged regions of the short arm of the X
chromosome, including all of the genes examined in the Xp
pseudoautosomal region; however, additional escapees are
distributed throughout the X chromosome (Carrel and
Willard 2005). The overall differences in expression
between the Xa and the Xi are reﬂected in the association
of the Xi with heterochromatic histone marks as well as a
lack of euchromatic histone marks (reviewed in Chow
and Heard 2009). The facultative heterochromatin of the
X chromosome provides an excellent system to study
epigenetic silencing, and one of the ﬁrst epigenetic marks
proposed to play a role in XCI was DNA methylation
(Riggs 1975).
In somatic cells, DNA methylation is found almost
exclusively at CpG dinucleotides (Lister et al. 2009),
which are underrepresented across the human genome but
are enriched at the promoters of 60% of genes, resulting
in regions known as CpG islands (Bird 1980; Weber et al.
2007). Deﬁnitions of what constitutes a CpG island differ
(Gardiner-Garden and Frommer 1987; Takai and Jones
2002); however, the use of three levels of CpG density:
high CpG density (HC), intermediate CpG density (IC)
and low CpG density (LC) allows for the unique prop-
erties of CpG islands to be dissected (Weber et al. 2007).
While autosomal promoters associated with CpG islands
are typically unmethylated in all tissues, a subset of
autosomal promoters has been found to show tissue-spe-
ciﬁc methylation. The regions surrounding CpG islands,
named CpG island shores, show the largest methylation
differences between tissues (Eckhardt et al. 2006; Irizarry
et al. 2009; Illingworth et al. 2008; Schilling and Rehli
2007). Genes on the X chromosome that are subject to
XCI typically have CpG islands that are unmethylated in
males, but show partial methylation in females; reﬂecting
that CpG island promoters on the Xa are unmethylated,
similar to autosomal CpG island promoters, while CpG
island promoters on the Xi are methylated (Cotton et al.
2009; Wolf et al. 1984a, b). Genes with CpG islands that
escape XCI appear to be unmethylated on both the Xa
and Xi (Goodfellow et al. 1988). The consistent rela-
tionship between X-linked CpG island promoter methyl-
ation and XCI status has been found in multiple
individual gene studies (Hansen and Gartler 1990; Carrel
et al. 1996; Anderson and Brown 2002) and a study of
neutrophils to propose novel genes which escape XCI
(Yasukochi et al. 2010). Multiple lines of evidence sup-
port that methylation is important to maintain XCI
including the reactivation of human X-linked genes upon
treatment with DNA methyltransferase inhibitors (Venolia
et al. 1982) and the high reactivation frequency for
X-linked genes from the hypomethylated marsupial Xi
during cell culture (Loebel and Johnston 1996; Kaslow
and Migeon 1987; Rens et al. 2010).
Approximately 50% of CpG islands overlap a known
transcription start site (TSS), with the remaining 50% of
CpG islands, called orphan CpG islands, being distributed
throughout the intragenic and the intergenic regions of the
genome (Illingworth et al. 2008, 2010). These orphan CpG
islands are often associated with promoter histone modiﬁ-
cations and RNA Pol II, suggesting that at least 40–60% of
orphan CpG islands are acting as promoters for currently
unknown genes (Illingworth et al. 2010). While the meth-
ylation status of CpG island promoters has been well
examined, fewer studies have examined non-promoter
regions. On the X chromosome the use of in situ nick
translation suggested that overall the Xi is hypermethylated
compared to the Xa; whereas the Xi is reported to be hy-
pomethylated compared with the Xa using methylation-
sensitive restriction enzymes (Prantera and Ferraro 1990;
Viegas-Pequignot et al. 1988). It appears that X-linked
gene bodies are hypermethylated on the Xa compared to
the Xi (Cotton et al. 2009; Weber et al. 2005; Hellman and
Chess 2007) and it has been proposed that this is due to
gene transcription on the Xa (Jones 1999). The link
between transcription and gene body methylation has not
just been detected on the X chromosome but across the
genome with highly expressed genes showing more gene
body methylation than genes with low expression (Aran
et al. 2011). Within genes, the 50 most exons show meth-
ylation which, like CpG island promoters, correlates with
gene silencing, while both internal exons and introns show
variable methylation (Brenet et al. 2011; Edwards et al.
2010). CpG island promoters only represent approximately
1% of the DNA of the X chromosome; therefore, the study
of methylation across other regions is important to gain a
complete picture of X chromosome-wide methylation
levels.
To study the distribution of X-linked methylation we
used the Illumina Inﬁnium HumanMethylation27 array and
analysed methylation at 777 X-linked promoters in human
blood and fetal somatic tissues (muscle, brain, spinal
cord and kidney). Methylated DNA ImmunoPrecipitation
(MeDIP) and hybridization to a NimbleGen 2.1M array
allowed for chromosome-wide methylation analysis in
human blood. Examination of methylation of X-linked
non-promoter regions revealed methylation differences
between the introns, but not exons, of highly versus lowly
expressed genes in both males and females. Our analysis of
X-linked promoters conﬁrmed that promoter methylation
differences between males and females are found primarily
at CpG islands on the X chromosome and not on the
autosomes. As has been previously shown on a single gene
level (Hansen and Gartler 1990; Carrel et al. 1996;
Anderson and Brown 2002), we demonstrated that
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123X-linked promoter methylation correlates well with the
XCI status of genes with CpG islands which in turn sug-
gests that the majority of unannotated CpG islands on the
X chromosome may be the promoters of genes subject
to XCI. Translating X-linked promoter methylation into a
genic XCI status across different tissues suggests that 12%
of genes show tissue-speciﬁc XCI in which the gene is
predicted to be subject to XCI in at least one tissue, but also
predicted to escape XCI in at least one tissue.
Materials and methods
Sample collection and DNA extraction
Collection of samples was approved by the ethics com-
mittees of the University of British Columbia and the
Children’s and Women’s Health Centre of British
Columbia. Whole blood samples (female n = 59 and male
n = 36) were collected from anonymous donors (ethics
approval number H08-02773) and peripheral blood
mononuclear cells (PBMCs) isolated using BD Cell Prep-
aration Tubes as per manufacturer’s instructions. DNA was
extracted using Qiagen AllPrep DNA/RNA mini kits as per
standard conditions. Fetal tissues (muscle: female n = 6
and male n = 4, spinal cord: female n = 2 and male
n = 1, brain: female n = 4 and male n = 4, kidney:
female n = 6 and male n = 5) were chromosomally
normal and collected from biopsied abortuses from
anonymous pregnancies terminated for medical reasons
(ethics approval number H06-70085). Genomic DNA was
extracted using a standard salting-out method as outlined in
Papageorgiou et al. (2009).
Illumina Inﬁnium HumanMethylation27 array
Genomic DNA was bisulﬁte modiﬁed with the EZ DNA
Methylation Kit (Zymo Research) as per the manufacturer’s
instructions and 180–200 ng of bisulﬁte DNA was then
ampliﬁed, fragmented and hybridized to Illumina Inﬁnium
HumanMethylation27 beadarray chips (Illumina, Inc) using
Illumina supplied reagents and conditions. The arrays were
scanned on the Illumina iScan system and imported into
GenomeStudio for further analysis (2010.2). Results were
subjected to a background normalization using BeadStudio
(versions 3.1.3.0 Illumina, Inc). Quantile normalization was
performed in R 2.11.0 using the limma package (Bolstad
etal.2003).Although beta-values are compressed when less
than 0.2 and greater than 0.8 and both of these ranges show
high heteroscedasticity, since we were interested in large
methylation differences between males and females for the
purposes of this paper beta-value was considered equivalent
to percent methylation (Du et al. 2010).
CpG density deﬁnitions
We used CpG density classiﬁcations based on those used
by Weber et al. (2007) to deﬁne three CpG densities: HC,
IC and LC. The program CpGIE (Wang and Leung 2004)
was used to deﬁne and locate HC and IC islands on the X
chromosome, chromosomes 20, 21 and 22. HCs had a GC
content greater than 55%, an observedCpG/expectedCpG
greater than 0.75 and were at least 500 bp in length. ICs
had a GC content greater than 50%, an observedCpG/
expectedCpG greater than 0.48 and were at least 200 bp in
length. Those ICs which overlapped with an HC were
excluded from the IC category but their HC component
remained in the HC category. In addition, all ICs
which overlapped with repetitive elements, as deﬁned by
RepeatMasker (Fujita et al. 2011; Smit et al. 1996–2010),
were not included in the IC category. LCs were all those
regions which were not HC or IC.
Illumina Inﬁnium HumanMethylation27 composition
and probes removed from analysis
The Illumina Inﬁnium HumanMethylation27 array is a
promoter array with all probes located in close proximity to
an annotated TSS. Approximately 45% of X-linked pro-
moters are represented on the array and those promoters
which overlap CpG islands (HC and IC) represent nearly
three quarters of the probes on the array despite the fact
that only 5% of CpGs on the X chromosome are located in
islands. The BLAST program (Altschul et al. 1990) from
NCBI was used to determine whether a probe sequence
mapped to a single unique location in the genome or to
multiple sites. Due to the large number of genes on the X
chromosome which have homologs on the Y chromosome,
probes which mapped to the Y chromosome as well the X
chromosome were not removed from the analysis. 153
X-linked and 134 autosomal (chr 20, 21 and 22) probes
were removed from the analysis due to mapping to more
than one location in the genome. 137 X-linked probes
located in the promoters of the cancer-testis (CT) family of
genes were removed from the analysis since they are
known to be methylated in all tissues except testis
regardless of CpG density (De Smet et al. 1999). To
determine if probes were located in repetitive elements,
probe locations were compared against the location of
known repetitive elements from RepeatMasker for UCSC
(Fujita et al. 2011; Smit et al. 1996–2010) which resulted in
the removal of 88 X-linked and 220 autosomal probes.
Statistical analysis
Statistical analysis of the Illumina Inﬁnium HumanMe-
thylation27 array was performed using the Mann–Whitney
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123test as calculated by Graphpad Prism. Statistical analysis of
MeDIP data was calculated in R (Team 2010) using the
Kolmogorov–Smirnov Test. Intrasex variation was calcu-
lated for each sex by comparing all combinations of sam-
ples using the Kolmogorov–Smirnov test. Due to the large
sample size, p values\0.0001 were considered signiﬁcant
and p values\1.0 E-10 highly signiﬁcant. In order for
the results to be considered signiﬁcant and to ensure the
difference between the average male and average female
methylation was larger than any differences within the
sexes, we required that the p value resulting from the
comparison of the average male and average female
methylation was smaller than the intrasex p values.
Decision tree to predict XCI status
Probes were predicted to escape XCI when the male
average and female average were unmethylated (\0.15%
methylated) and when males and females showed a similar
range of methylation (either the range of male and female
methylation overlapped or, if the ranges did not overlap,
the difference between the male and female average was
less than 10%). Probes were predicted to be subject to XCI
when males and females showed a different range of
methylation where the difference between the male average
and female average was greater than 10%. Probes were
predicted to variably escape XCI when although the dif-
ference between the male and female average was greater
than 10% there was also an overlap in the range of male
and female methylation. When the male and female aver-
ages were greater than 15% and/or the difference between
the male and female average was less than 10% probes
were deﬁned as unclassiﬁable. Supplementary Figure S1
outlines the decision tree.
RNA extraction and Q-PCR
RNA from four somatic cell hybrids containing a human Xi
(t75-2maz34-4a, t48-1a-1Daz4A, t86-B1maz1b-3a and
t11-4Aaz5), two somatic cell hybrids containing a human
Xa (AHA-11aB1 and t60-12) and a control female cell line
(GM7350) was extracted using Trizol (Invitrogen) as per
the manufacturer’s protocol and 5 lg converted to cDNA
via a standard RT-PCR reaction using M-MLV (Invitro-
gen) at 42C for 2 h followed by a 5 min incubation at
95C. Real-time quantitative PCR (Q-PCR) was performed
using the StepOnePlus
TM Real-Time PCR System (Applied
Biosystems, Darmstadt, Germany) on each sample in
triplicate with the following conditions: 95C (5 min),
[95C (30 s), 60C (30 s), variable annealing temperature
(30 s)] for 40 cycles and melting curve analysis [95C
(15 s), 60C (60 s) then ﬂuorescence was measured every
0.3C per until 95C]. Primer sequences and annealing
temperatures are listed in Supplementary Table S1. The
average of three triplicate Ct values were corrected based
on the average efﬁciency for each assay, as calculated by
LinReg (Ramakers et al. 2003; Ruijter et al. 2009) and
delta Ct values calculated for TSR2 and ZRSR2 compared
to ZFX. The negative and positive error was calculated
based on the sum of the standard deviation for the test
(TSR2 or ZRSR2) and the control (ZFX) assay for each
sample (in triplicate). All assays were found to not amplify
mouse gDNA (data not shown).
MeDIP and whole genome ampliﬁcation
MeDIP of male (n = 3) and female (n = 3) blood was
performed as outlined in Vucic et al. (2009). Brieﬂy, three
reactions of 1 lg of genomic DNA were sonicated then
200 ng of input removed. The remaining 800 ng of DNA
was denatured (95C, 10 min) then 5 lg of anti-50-methyl-
cytosine mouse mAb (CalBiochem) added before incu-
bating at 4C for 2 h. 30 lL of Dynabeads M-280 Sheep
anti-Mouse IgG (Dynal Biotech, Invitrogen) were then
added followed by a 2 h incubation at 4C. Two rounds of
washing were performed to remove the Dynabeads then
100 lg of proteinase K was added and left overnight at
50C. A phenol:chloroform clean-up was performed the
next day and DNA resuspended in 10 lLH 2O. Whole
genome ampliﬁcation was performed using the Genome-
Plex Complete Whole Genome Ampliﬁcation Kit (Sigma)
according to the manufacturer’s instructions.
NimbleGen array processing and analysis
Three reactions using 1 lg of whole genome ampliﬁed
DNA for each sample were labeled using Cy3-9mer
primers for input and Cy5-9mer primers (TriLink Bio-
technologies, Inc.) for IP. Labeling was performed as
outlined in the NimbleGen Arrays User’s Guide: ChIP-chip
Analysis v3.0 (Roche NimbleGen, Inc) then samples were
sent to the Fred Hutchinson Cancer Research Center
(Seattle, WA, USA) for hybridization to a Human ChIP-
chip 2.1M Whole-Genome Tiling, array number 10 (Roche
NimbleGen, Inc). Files of the scanned arrays were pro-
cessed according to the NimbleGen Arrays User’s Guide:
DNA Methylation Analysis v5.0 and the resulting ratio
ﬁles subjected to BATMAN (Bayesian Tool for Methyla-
tion Analysis) (Down et al. 2008) to correct the effect of
CpG density of MeDIP efﬁciency. The average standard
deviation of the three samples was 0.05 in males and
females. To ensure that samples were more similar within a
sex than between, the 6 blood samples were combined in
all 18 possible combinations of three and the average
standard deviation (0.06) of all 18 combinations was
always greater than that observed within each sex. Galaxy
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123(Goecks et al. 2010; Blankenberg et al. 2010) was then
used to calculate the frequency of probes in the various
genomic elements examined.
Expression data
Expression ratios on log base 2 scale from Su et al. (2002)
in whole blood were downloaded from http://symatlas.gnf.
org. Genes were divided by chromosome and ranked from
lowest to highest expression. The top and bottom 20% of
genes from each chromosome were used to represent those
genes with the lowest and highest expression levels in
blood.
Results
X-linked promoters show differences in methylation
dependent on sex and CpG density
To determine how X-linked promoter methylation differed
between the sexes we applied DNA from 36 male and 59
female bloods to the Illumina Inﬁnium HumanMethyla-
tion27 array containing 1,085 X-linked probes. A total of
308 X-linked probes were removed from analysis as they
were located in repetitive elements, mapped to more than
one location in the genome and/or were located in the
promoters of the cancer-testis family of genes (summarized
in Supplementary Figure S1). To detect the large methyl-
ation differences between males and females previously
reported at most X-linked promoters, we created three
broad methylation classes: unmethylated (0–0.15 beta
value), intermediate (0.15–0.60 beta value) and methylated
(0.60–1.00 beta value) and then separated the remaining
777 X-linked probe results into one of the three methyla-
tion classes. The majority (67%) of the X-linked probes in
male blood were shown to be unmethylated whereas the
majority (66%) of probes in female blood had intermediate
methylation. As CpG density is known to inﬂuence meth-
ylation we sub-divided probes based on their location
within HC and IC islands or LCs. X-linked promoter
probes in HC and IC islands were generally those which
were unmethylated in male blood and intermediately
methylated in female blood, whereas X-linked promoter
probes in LCs were usually methylated in both sexes
(Fig. 1a).
To ensure that the observed X-linked methylation dif-
ferences between males and females were not simply due
to differences in overall methylation between the sexes,
autosomal methylation levels were compared between the
same male and female blood samples. Male and female
probes (1,843 probes located on chromosomes 20, 21 and
22) were compared after removal of 307 autosomal probes
that were located in repetitive elements and/or mapped to
multiple locations in the genome. The majority (98%) of all
autosomal probes showed the same methylation level in
males and females regardless of CpG density. Furthermore,
those probes at which males and females had different
methylation classes (unmethylated, intermediate or methyl-
ated) showed only a 2% difference in methylation
and were not signiﬁcantly different in their methylation,
making it unlikely that this difference was biologically
functional. We therefore conclude that the differences
between male and female methylation is mostly unique to
the X chromosome and occurred primarily at X-linked
promoter probes located in HC and IC islands (Fig. 1b).
Given that 10% of X-linked probes in HC and IC islands
were unmethylated in females, and that unmethylated
X-linked promoters have previously been found at genes
which escape XCI (Carrel et al. 1996) we wanted to
Fig. 1 Promoter methylation analysed in blood (female: n = 59 and
male: n = 36) revealed X chromosome sex-speciﬁc methylation
differences as well as differences based on CpG density. Probes were
divided by CpG density (LC black,I Cgray,H Cwhite) and classiﬁed
as unmethylated (0–15% methylated), intermediate (15–60% methyl-
ated) or methylated (60–100% methylated) in males and females.
a Methylation levels in males and females were signiﬁcantly different
(p value\0.0001, Mann–Whitney test) across all X-linked probes.
The majority of HC and IC promoter probes (n = 560) on the X
chromosome were unmethylated in males and intermediate in
females. X-linked LCs probes (n = 217) were mostly methylated
regardless of sex. b Methylation levels in males and females were not
signiﬁcantly different (p value = 0.2779, Mann–Whitney test) across
autosomal probes. The majority of promoter probes on chromosomes
20, 21 and 22 were unmethylated. Probes in HC and ICs (n = 1088)
were mostly unmethylated whereas LC (n = 448) probes were mostly
methylated. Males and females showed no differences in their
methylation classes
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and IC islands in males and females reﬂected escape from
XCI as was previously proposed by (Yasukochi et al. 2010).
Assessment of promoter methylation as a predictor
of XCI status
Before we could evaluate how effectively X-linked pro-
moter methylation might predict the XCI status of a gene,
we had to establish a consistent method of translating male
and female methylation results from multiple probes into a
single genic XCI status. We developed a decision tree
examining the average male and average female methyla-
tion levels, the difference between these averages and the
range of methylation observed in males and females to call
the XCI status of each probe (Supplementary Figure S1).
The majority of probes in genes with HC and IC islands
(77%) predicted the gene was subject to XCI, 11% pre-
dicted escape from XCI, 3% variable escape and 8% were
unclassiﬁable. The 560 probes in HC and IC islands were
found in 343 X-linked genes (145 genes were represented
by only 1 probe), therefore probes from the 198 genes that
contained more than one probe in an HC or IC island were
combined to create a single predicted XCI status for each
gene. For 90% of genes, all probes (if multiple probes were
present) predicted the same XCI status. Of the remaining
10% of genes, over half had one probe where an XCI status
was predicted with the other probe being unclassiﬁable.
These genes were, therefore, given the XCI status of the
probe which had predicted an XCI status (subject, escape
or variable escape). In only 5 genes out of the 343 X-linked
genes was there a conﬂict in which 1 probe predicted an
XCI status of escape and the other subject to XCI was
found (Supplementary Table S2). Interestingly, all ﬁve of
these were found in genes that had previously been
reported to escape, or variably escape XCI (Carrel and
Willard 2005). We predicted that the majority (81%) of
genes with probes in HC or IC islands were subject to XCI,
10% escaped XCI, 2% variably escaped XCI and 5% of
genes remained unclassiﬁable (Fig. 2a). Of the 19 unclas-
siﬁable genes, 13 were methylated in both males and
females. Overall we were able to use methylation to predict
an XCI status for 95% of examined X-linked genes with
probes in HC or IC islands and could therefore compare
these predictions to the XCI status of the same genes
previously determined by expression.
To examine whether X-linked promoter methylation
was effective at predicting XCI status, we analyzed genes
at which the XCI status had previously been established
and determined the degree to which our predicted XCI
status agreed. We compared our predicted XCI status in
blood with the XCI status derived from reported studies of
somatic cell hybrids by Carrel and Willard (2005). Since
the bulk of X-linked genes are subject to XCI we ﬁrst
Fig. 2 The XCI status predicted using methylation in blood corre-
sponds with previously determined XCI status. a The XCI status
(subject black, variable escape diagonal stripes, escape white,
unclassiﬁable gray, conﬂicts dotted) of 372 X-linked genes with
probes in HC and IC islands was predicted using methylation. The
percentage of the total X-linked genes with probes in HC and IC
islands is given for each predicted XCI status. In blood, the majority
(81%) of genes are predicted to be subject to XCI. b The XCI status
previously determined by Carrel and Willard (2005) in somatic cell
hybrids (subject black, variable escape diagonal stripes, escape white)
for those genes predicted by methylation to be subject to XCI (black
bar in a and top pie chart) and those genes predicted to escape XCI
(white bar in a and bottom pie chart). c–d Q-RT-PCR conﬁrmation in
somatic cell hybrids of predicted XCI status based on methylation.
The expression level of two genes (TSR2 and ZRSR2) in four somatic
cell hybrids containing a human Xi (white t75-2maz34-4a, t48-1a-
1DAZ4A, t86-B1maz1b-3a and t11-4Aaz5), two somatic cell hybrids
containing a human Xa (light gray AHA-11aB1 and t60-12) and a
control female cell line (dark gray GM7350) were compared to
conﬁrm that methylation could predict XCI status. Test genes (TSR2
and ZRSR2) were normalized against a gene known to escape XCI
(ZFX). Error bars represent the positive and negative error between
three replicate PCRs. c TSR2 was unmethylated in male blood and
intermediate in female blood and was predicted to be subject to XCI.
d ZRSR2 was unmethylated in male and female blood and was
predicted to escape XCI
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123examined the genes with probes in HC or IC islands which
we predicted to be subject to XCI. After the removal of
genes not examined by Carrel and Willard (2005), 83%
(n = 192) of the genes predicted by X-linked promoter
methylation to be subject to XCI were also found by Carrel
and Willard (2005) to be subject to XCI. Given our interest
in using X-linked promoter methylation to predict escape
from XCI we also examined those genes with probes in HC
or IC islands for which our methylation data had predicted
escape from XCI. Here we found that 72% of genes pre-
dicted by X-linked promoter methylation to escape XCI
were also shown by Carrel and Willard (2005) to escape
XCI (Fig. 2b). To further address the ability of promoter
methylation to predict XCI status, the expression patterns
of two genes (TSR2 AND ZRSR2) not examined by Carrel
and Willard (2005) were examined by Q-PCR in somatic
cell hybrids (four hybrids containing a human Xi and two
containing a human Xa) as well as a control female cell
line. Based on promoter DNA methylation, TSR2 was
predicted to be subject to XCI and this was conﬁrmed, as
none of the Xi hybrids showed expression comparable to
the Xa hybrids or the female cell line. ZRSR2 was predicted
to escape XCI and this too was conﬁrmed with all Xi
hybrids showing expression at least as high as the Xa
hybrids and the female cell line (Fig. 2c, d).
This validation, along with the high degree of agreement
between previously determined XCI status and our pre-
diction using X-linked promoter methylation, led us to
believe that the methylation of probes in HC and IC islands
X-linked promoters can be used to predict XCI status and,
therefore, we can propose an XCI status for 62 genes (see
Supplementary Table S3). A few of these have been
described in other studies and our prediction of XCI is in
agreement (Brinkman et al. 2006; Yasukochi et al. 2010;
Lopes et al. 2006). While our results suggest that methyl-
ation is an effective predictor of XCI status, 59 genes were
shown by Carrel and Willard (2005) to have a different
XCI in somatic cell hybrids than was predicted by our
analysis of methylation in blood. Tissue-speciﬁc escape
from XCI has been reported in mouse (Yang et al. 2006)
and therefore we wished to investigate the extent to
determine if tissue-differences could be a substantial con-
tributor to the 15% discordance we observed between the
XCI status in somatic cell hybrids and blood (Carrel and
Willard 2005).
Tissue-speciﬁc XCI is observed at 12% of genes
We extended our Illumina Inﬁnium HumanMethylation27
array analysis to fetal tissues (muscle, kidney, brain and
spinal cord) to determine if all tissues showed the same
male and female methylation, and therefore the same pre-
dicted XCI status. We ﬁrst conﬁrmed that, as with blood,
there was a sex-speciﬁc methylation difference that was
limited to the X chromosome and not the autosomes
(Supplementary Figure S2). We then examined fetal mus-
cle and fetal kidney and combined fetal brain and fetal
spinal cord into one fetal ‘‘neural’’ tissue category. The
same process of predicting XCI status as was used in blood,
again demonstrated that although the level of methylation
was signiﬁcantly different between tissues (p\0.0001),
the majority of X-linked CpG-island genes showed a
pattern of methylation consistent with being subject to
XCI (unmethylated males and intermediate females)
regardless of the tissue examined (blood = 81%, fetal
muscle = 74%, fetal neural = 66%, fetal kidney = 73%).
Interestingly, a larger proportion of X-linked genes showed
a pattern of methylation that we considered predictive of
escape from XCI in fetal tissues (muscle = 15%, neu-
ral = 17%, kidney = 15%) compared to blood (10%),
despite the considerably smaller sample size, which led us
to compare the predicted XCI in all tissues to determine
how often the same XCI status was predicted in all tissues
(Fig. 3a).
We compared the predicted XCI status across all tissues
and found that the majority (78%) of X-linked genes
showed the same predicted XCI status in all tissues
examined. An additional 6% of genes showed the same
predicted XCI status in all but one tissue (which was
designated unclassiﬁable). However, at 12% of X-linked
genes, promoter methylation resulted in a different pre-
dicted XCI status in different tissues (Fig. 3b) and we
designated these genes as showing tissue-speciﬁc XCI. Of
the genes which showed tissue-speciﬁc XCI, nearly half
(48%) show more escape in the fetal tissues compared to
blood. Supplementary Table S4 lists genes which displayed
tissue-speciﬁc XCI, and the locations of these genes are
shown in Fig. 4 along with the location of genes that
showed consistent XCI patterns. The distribution of these
genes is inﬂuenced by the choice of probes on the array,
and notably no pseudoautosomal probes were included.
Our ﬁnding that X-linked promoter methylation differs
across 12% of genes examined suggests tissue-speciﬁc XCI
in these genes.
To investigate if tissue-speciﬁc XCI was consistent
between females we examined six different females each
with at least two different fetal tissues. We compared the
predicted XCI status in fetal tissues (muscle, neural tissue
and kidney) from four females, fetal muscle and fetal
kidney from one female and fetal neural and fetal kidney
from another female. We used the individual female’s
methylation value along with the average male methylation
in the same tissue to predict XCI status. In each female
examined, 84–86% (see Supplementary Table S5) of the
total X-linked genes examined were predicted to escape or
be subject to XCI across all tissues, while 8–14% of genes
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speciﬁc XCI. In females with multiple tissues, fetal muscle
showed the fewest genes with tissue-speciﬁc escape while
fetal neural tissue showed the most. We found that when
escape from XCI was predicted by X-linked promoter
methylation in one tissue, it was generally predicted in all
tissues (listed in Supplementary Table S6). Overall, DNA
methylation-based evidence for tissue-speciﬁc XCI was
found in all females examined, with the highest degree of
tissue-speciﬁc escape always observed in fetal neural tissue
but with a great deal of variability between females.
X-linked non-island methylation is a poor predictor
of XCI status
Having established that the X-linked promoter methylation
of probes in HC and IC islands was highly predictive of
XCI status, we were interested if the same methodology
could be applied to LC probes (those not located in HC and
IC islands). It should be noted that the majority of probes
on the Illumina Inﬁnium HumanMethylation27 array are
located in CpG islands (65%) associated with promoters.
Some X-linked LC promoters have been reported to exhibit
methylation that correlates with gene silencing on the Xi
[such as TIMP1 (Anderson and Brown 2002), CHM (Carrel
and Willard 1999), and OTC (Yorifuji et al. 1998)]. The
same decision tree (Supplementary Figure 1) used to pre-
dict the XCI status of probes in HC and IC islands was
applied to LC probes to evaluate what proportion of LC
probes showed a methylation status which could predict an
XCI status. Approximately one quarter (27%) of all LC
probes examined were located in promoters (±1 kb around
the TSS) which also included an HC or IC island while the
remaining LC probes were located in promoters which
lacked an HC or IC island. LC probes were generally
unclassiﬁable (82%) due to high methylation regardless of
whether a CpG island was present within the promoter
region. The remaining probes showed methylation patterns
classiﬁable as escape (4%), variable escape (4%) or subject
to XCI (genes with CpG islands: 21%, genes without CpG
islands: 7%). Those LC probes with a methylation status
which predicted an XCI status of subject, variable escape
or escape, along with any HC or IC probes in the same
gene are listed in Supplementary Table S7. We compared
the XCI status predicted using methylation to that deter-
mined by Carrel and Willard (2005) and found that
approximately 40% of LC probes predicted the same XCI
status as Carrel and Willard (2005) regardless of whether
the LC probe was in the promoter of a gene with a CpG
island or not. Given the low concordance between the
predicted XCI status based on LC probe methylation and
that previously determined by Carrel and Willard (2005),
we conclude that LC probes are not usually reliable as a
predictor of XCI status.
X-linked HC and IC promoters show the strongest
sex-speciﬁc methylation difference
The data we analysed from the Illumina Inﬁnium Hu-
manMethylation27 array examined only approximately
45% of X-linked promoters and did not examine any non-
promoter elements such as the intragenic and intergenic
regions of the chromosome. To expand the study of
X-linked methylation beyond promoters, MeDIP was per-
formed on DNA isolated from male (n = 3) and female
(n = 3) blood followed by hybridization to a NimbleGen
2.1M array to analyse chromosome-wide methylation of
chromosomes 20, 21 and 22 along with the X chromosome.
Fig. 3 Most genes show the same predicted XCI status in all tissues
examined while 12% of genes show tissue-speciﬁc XCI. a Male and
female methylation was used to predict XCI status (as outlined in
Supplementary Figure S1) of genes with probes in HC and IC islands
in fetal muscle (black, female n = 6; male n = 4), fetal neural tissue
(gray, female n = 6; male n = 5) and fetal kidney (white, female
n = 6; male n = 5). b The combined predicted XCI status in all four
tissues examined (blood, fetal muscle, fetal neural and fetal kidney).
The majority of genes showed the same XCI status (subject black,
variable escape diagonal stripes, escape white, unclassiﬁable gray,
conﬂicts dotted) in all tissues. 6% of genes were unable to predict an
XCI status in at least one tissue but predicted same XCI status in all
other tissues (horizontal stripes). 12% of genes showed tissue-speciﬁc
methylation differences which resulted in at least one tissue having a
different predicted XCI from the other tissues (dark gray)
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ciency, BATMAN (Down et al. 2008) was used to convert
the ratio of IP:IN into a methylation value from 0 to 1.
BATMAN was performed on all samples and the resulting
scores averaged to create one average male score and one
average female score, in subsequent analyses only male
versus female differences that were greater than intrasex
differences were considered for statistical signiﬁcance.
Methylation histograms were compiled to assess the dis-
tribution of methylation on different DNA elements of
interest.
To determine if the X-linked sex-speciﬁc methylation
difference found using the Illumina Inﬁnium HumanMe-
thylation27 array could also be observed via MeDIP, the
ﬁrst elements we examined were X-linked promoters.
Promoters were deﬁned as the probes within 1 kb up and
downstream of all TSS, therefore the presence of an HC
island in a promoter, or the presence of an IC but not an
HC, resulted in the classiﬁcation of HC or IC promoter,
respectively. LC promoters were those promoters which
had neither an HC nor IC island in the region 1 kb
upstream and downstream of the TSS. X-linked HC pro-
moters showed a higher frequency of unmethylated probes
in the male than the female with a signiﬁcantly different
(D = 0.12, p\2.2 E-16) distribution between the sexes
(Fig. 5a). IC promoters on the X chromosome showed a
signiﬁcantly different (D = 0.07, p = 2.5 E-10) distri-
bution between the sexes and were slightly more unme-
thylated on the male X chromosome than on the female X
chromosomes. In addition, X-linked IC promoters also had
a higher percentage of both male and female probes being
intermediate or fully methylated than was observed in HC
promoters (Supplementary Figure S3a). On the autosomes,
neither HC nor IC promoters were signiﬁcantly different
between males or females, however, HC promoters were
mostly unmethylated while IC promoters also showed
intermediate methylation. X-linked LC promoters were
mostly methylated and were not signiﬁcantly different
between males and females while autosomal LC promoters
were slightly less methylated (Fig. 5b). By examining all
known X-linked promoters we were able to show that sex-
speciﬁc methylation differences were highly signiﬁcant at
X-linked HC promoters, slightly signiﬁcant at X-linked IC
promoters but not signiﬁcant at X-linked LC promoters or
on the autosomes.
Our deﬁnition of promoter elements comprised only
approximately 2% of base pairs on the X chromosome;
therefore, determining the methylation status at non-pro-
moter elements was of critical importance if an overview of
chromosome-wide methylation was to be established.
Intragenic and intergenic regions showed similar methyl-
ation in males and females; however, on the X chromo-
some these regions were bimodally distributed whereas on
the autosomes they were not (Fig. 5c, d). Across the gen-
ome there are CpG islands not currently associated with
known genes. Males and females displayed signiﬁcantly
different methylation at HC islands not associated with a
knownTSSontheXchromosome(D = 0.09,p = 2.4E-9)
but not on the autosomes nor at X-linked or autosomal IC
islands not associated with a known TSS. The IC islands
were more methylated in both sexes than IC promoters on
either the X chromosome or the autosomes (Supplementary
Figure S3b and c). Having compared elements across the
entire X chromosome we conﬁrmed that although HC
Fig. 4 Genes predicted to show tissue-speciﬁc XCI based on
methylation from the Illumina Inﬁnium HumanMethylation27 array
as found across the X chromosome. The genomic locations of genes
which showed the same predicted XCI status in all tissues examined
(escape green, subject red) are shown to the left of the X chromosome
ideogram. On the right are the genomic locations of genes in which at
least one tissue had a predicted XCI status different from the other
tissues. The predicted XCI status (subject red, variable escape purple,
escape green, unclassiﬁable gray, conﬂict yellow) in each tissue
examined (blood, fetal neural, fetal muscle and fetal kidney) is shown
along with the names of all genes which show tissue-speciﬁc XCI
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they are the element which showed the strongest degree of
X-linked sex-speciﬁc methylation.
X-linked genes with high expression show high
gene-body methylation
It has previously been shown that the intragenic regions of
highly expressed genes are more methylated than those of
lowly expressed genes (Aran et al. 2011) and on the X
chromosome gene-bodies of the Xa have been found to be
more methylated than on the Xi (Hellman and Chess 2007).
We therefore used published expression data (Su et al.
2002) to separate genes with high expression levels (top
ranking 20%) from those with low expression (bottom
20%) to allow for a male:female comparison of gene-body
methylation levels relative to expression levels. No sig-
niﬁcant differences between the distribution of male and
female methylation were found at exons or introns on
either the X chromosome or the autosomes. However,
X-linked introns of highly expressed genes were more
methylated than those of lowly expressed genes in both
males and females (Fig. 6a, b). Interestingly, X-linked
exons did not show this differences between highly and
lowly expressed X-linked genes. Overall, the division of
genes based on expression did not demonstrate a signiﬁcant
difference in the distribution of male:female methylation
although X-linked intronic methylation was greater in more
highly expressed genes compared to lowly expressed
genes.
Discussion
The presence of methylation at X-linked CpG island pro-
moters on the Xi is classically associated with genes sub-
ject to XCI (Cotton et al. 2009; Jamieson et al. 1996). We
found that in all tissues examined (blood, fetal muscle, fetal
Fig. 5 Methylation histograms reveal X-linked HC promoters show
the largest X-linked sex-speciﬁc methylation difference. The average
male and average female methylation from probes representing four
different genomic elements was used to create methylation histo-
grams by determining the frequency at which probes were at a
speciﬁc level of methylation (20 bins from 0 to 1.0 methylated).
Female methylation frequencies are shown as dotted lines and males
as solid lines with methylation frequencies from the X chromosome
displayed on the upper row and the autosomal average from
chromosomes 20, 21 and 22 on the bottom. The percentage of the
total chromosomal DNA each element represents is given for the X
chromosome and the autosomes (chromosomes 20, 21 and 22).
Signiﬁcance was calculated comparing the distribution of average
male and average female methylation using the Kolmogorov–
Smirnov test. When p values were greater than 0.0001 they were
not signiﬁcant, however, p values between 0.0001 and 1.0 E-10
(asterisk) and p values\1.0 E-10 (double asterisk) were considered
signiﬁcantly different. a–b Promoter elements (the 1 kb up and
downstream of all TSS) showed differences in methylation frequen-
cies based on CpG density. HC promoters (a) showed males were
hypomethylated compared to females on the X chromosome but not
the autosomes. LC promoters (b) (contained neither an HC nor IC
island) showed no sex-speciﬁc methylation difference on either the X
chromosome or the autosomes. c–d Non-promoter elements tended to
be methylated on the male and female X chromosome and interme-
diately methylated on the autosomes in both intragenic (c) and
intergenic (d) regions
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X-linked promoter probes in HC and IC islands were un-
methylated in males and intermediately methylated in
females which is the pattern of methylation typically
associated with genes subject to XCI. In support of this sex
difference being reﬂective of XCI, nearly all autosomal
probes (over 95%) showed the same methylation status in
males and females, regardless of CpG density. Genes
which escape XCI have previously been found to be un-
methylated in both males and females (Carrel et al. 1996)
and this unique property has been used to propose novel
genes which escape XCI (Yasukochi et al. 2010) in neu-
trophils. We extended the search for genes which escape
XCI to blood, fetal muscle, fetal kidney and fetal neural
tissue using the DNA methylation pattern for genes with
probes in HC and IC islands. We found a high degree of
concordance (81%) with the XCI status previously deter-
mined by Carrel and Willard (2005) in somatic cell
hybrids; however, for 19% of genes there was discordance
between our methylation-based prediction in blood and
results from expression in hybrids.
Previous studies which have examined XCI status have
typically used either somatic cell hybrids or females with
clonal XCI who are heterozygous for known SNPs (Carrel
and Willard 2005). Similar to our results, previous com-
parisons between expression in hybrids and in female tis-
sues have shown discordancies (Carrel and Willard 2005;
Stabellini et al. 2009). We propose several different rea-
sons for the differences between the XCI status we pre-
dicted using methylation and that of Carrel and Willard
(2005). First, methylation may not always be an accurate
predictor of XCI status. This might occur in regions where
other epigenetic marks, such as histone modiﬁcations, are
more important to maintain XCI. A second possible
explanation is that due to the proposed decrease in stability
of XCI of somatic cell hybrids (Gartler and Goldman 1994;
Stabellini et al. 2009) genes which are typically subject to
XCI in blood now escape XCI in somatic cell hybrids. If
the differences in XCI were caused by a decrease in sta-
bility of XCI in somatic cell hybrids then any conﬂicts in
XCI status should involve a higher degree of escape from
XCI in the somatic cell hybrids. 15% of genes examined
showed more escape from XCI in the somatic cell hybrids
than in blood supporting this hypothesis, however, 4% of
genes showed more escape in blood than the somatic cell
hybrids. These conﬂicts cannot be explained by a decrease
in the stability of XCI in somatic cell hybrids, suggesting
that hybrid instability is not the full explanation.
A third possibility is that somatic cells hybrids and
blood actually have different XCI statuses at a subset of
genes. We attempted a direct comparison of methylation in
hybrids (data not shown) with expression status for indi-
vidual genes; however, we observed considerable vari-
ability of methylation between hybrids, even in Xa hybrids
(data not shown) and were thus not able to compare
methylation to expression in the hybrids. We therefore
examined male and female methylation levels in different
human tissues to determine if tissue-speciﬁc methylation
changes were frequent. While most genes had the same
predicted XCI status in all tissues examined, we detected
potential tissue-speciﬁc XCI in 12% of genes, the majority
of which reﬂected genes being subject to XCI in blood
while at least one other tissue was not subject to XCI. We
also found that over 50% of genes showing tissue-speciﬁc
Fig. 6 X-linked introns but not exons show differences in methyl-
ation based on expression level. The average male and average female
methylation from probes representing four different genomic ele-
ments was used to create methylation histograms by determining the
frequency of probes at a speciﬁc level of methylation (20 bins from 0
to 1.0 methylated). Female methylation frequencies are shown as
dotted lines and males as solid lines with methylation frequencies
from the X chromosome displayed on the upper row and the
autosomal average from chromosomes 20, 21 and 22 on the bottom.
X-linked and autosomal (chromosomes 20, 21 and 22) genes were
separated based on expression (determined in Su et al. 2002) and the
top (light gray) and bottom (dark gray) 20% divided into those which
correspond to either the exons (a) or introns (b). Signiﬁcance was
calculated comparing the distribution of male and female methylation
using the Kolmogorov–Smirnov test. When p values were greater
than 0.0001 they were not signiﬁcant (ns), however, p values between
0.0001 and 1.0 E-10 (asterisk) and p values\1.0 E-10 (double
asterisk) were considered signiﬁcantly different. While exons
(a) were similarly methylated regardless of sex or expression level
on both the X chromosome and the autosomes, introns (b) were more
methylated in highly expressed X-linked genes than lowly expressed
X-linked genes in both sexes. Autosomal introns showed no
methylation difference in either sex
Hum Genet (2011) 130:187–201 197
123XCI were found within 1MB of each other suggesting a
possible regional effect causing tissue-speciﬁc XCI. We
caution that when examining X-linked genes the XCI status
should always be conﬁrmed in the tissue of interest. The
degree of predicted tissue-speciﬁc XCI differed between
the six examined females and between tissues, with neural
tissue showing the highest degree of predicted tissue-
speciﬁc escape from XCI. Studies examining expression
amongst all X-linked genes have consistently shown brain
to have one of the highest X:autosome ratios, regardless
of the technique being used (Xiong et al. 2010). The
X chromosome contains an overrepresentation of genes
expressed in the brain (Nguyen and Disteche 2006; Vicoso
and Charlesworth 2006) and many X-linked genes are
known to play a role in X-linked mental retardation
[reviewed in (Ropers 2006)] which is signiﬁcantly more
common in males than in females (Turner and Turner
1974; Croen et al. 2001). Expression of genes from the Xi
when the Y homolog is no longer functional could lead
to a dosage difference between males and females, and
might contribute to sex-speciﬁc differences in disease
susceptibility.
On the autosomes, tissue-speciﬁc methylation differ-
ences in CpG islands have previously been detected across
a number of tissues (Rakyan et al. 2008; Eckhardt et al.
2006; Irizarry et al. 2009; Illingworth et al. 2008; Schilling
and Rehli 2007) and it has been proposed that the majority
of tissue-speciﬁc differentially methylated regions are
located in the regions surrounding CpG islands known as
CpG island shores (Irizarry et al. 2009). We found that the
majority of probes which showed tissue-speciﬁc XCI
(83%) were located in HC islands rather than shores. The
criteria we used to detect sex-differences on the X chro-
mosome were designed to identify large changes in meth-
ylation associated with the XCI status of the gene which
may explain why the tissue-speciﬁc methylation we
observed on the X chromosome was mostly located in the
CpG islands and not in the shores as was previously
reported on the autosomes (Irizarry et al. 2009). Our
analysis of X-linked HC non-promoters (HC islands not
associated with a known promoter) revealed a similar hy-
pomethylation in male blood compared to female blood.
The presence of a sex-speciﬁc methylation difference is
evidence that these HC islands may be the promoters of
unannotated X-linked genes that are subject to XCI. This is
in agreement with a previous report in which the majority
of genome-wide orphan CpG islands were predicted to be
associated with the promoters of unknown genes based on
histone modiﬁcations and the presence of RNA Pol II
(Illingworth et al. 2010). The X-linked IC non-promoter we
examined lacked a signiﬁcant sex-speciﬁc methylation
difference suggesting that it is less likely that these CpG
islands are associated with unknown genes. To conﬁrm that
the X-linked non-promoters islands we were predicting to
be promoters were in fact not enhancers, we examined the
histone modiﬁcations typically associated with enhancers
(Heintzman et al. 2007) and did not ﬁnd any signiﬁcant
enrichment (data not shown).
Across the genome, the most widely expressed genes
tend to have a promoter CpG island along with a smaller
subset of tissue-speciﬁc genes (Gardiner-Garden and
Frommer 1987). On the X chromosome, some genes,
notably androgen receptor, which has been widely used to
examine XCI skewing, also have tissue-speciﬁc expression
(Su et al. 2002) yet show consistent methylation (males:
unmethylated, females: *50% methylated) even in tissues
where they are not expressed (Bittel et al. 2008). Consistent
with this observation, data from the Illumina Inﬁnium
HumanMethylation27 array showed that female X-linked
promoters had no differences in methylation between
highly and lowly expressed genes at any CpG density while
males showed a slight signiﬁcance at X-linked IC pro-
moters. Chromosome-wide methylation analysis revealed
that the HC promoters of highly expressed X-linked genes
maintained a signiﬁcant difference between males and
females (data not shown), where males were more hy-
pomethylated than females. On both the X chromosome
and the autosomes, all other promoters showed no signiﬁ-
cant difference between the distribution of males and
female methylation at either highly or lowly expressed
genes.
The association between promoter methylation and
transcriptional silencing is well established (Saxonov et al.
2006; Gardiner-Garden and Frommer 1987; Bird 1986);
however, the interaction between gene-body methylation
and transcription, as well as the methylation status of
intergenic regions, is less clear. In general, the distribution
of methylation in intragenic and intergenic regions of the
X chromosome is different from the autosomes, likely
reﬂecting the unique sequence composition of the sex
chromosomes. This difference is less apparent at exons
where the distribution of methylation on the X chromo-
some is more similar to the autosomes. When X-linked
introns are examined the methylation of the top 20% of
expressing genes differs from the bottom 20% of genes,
whereas on the autosomes expression does not greatly
affect the distribution of methylation. The shift of meth-
ylation of highly expressed X-linked introns yields a dis-
tribution of methylation very similar to that found at all
X-linked exons. Although we do not observe a signiﬁcance
difference between the distributions of male and female
methylation we do see that highly expressed X-linked
introns are more methylated than lowly expressed introns.
A role for transcription in gene-body methylation is sup-
ported by a recent genome-wide study which showed that
early replicating genes have more gene body methylation
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study showed methylation of the gene body was more
likely to be found in highly expressed genes (Brenet et al.
2011). Differences in autosomal exon and intron methyl-
ation have previously been found, with ﬁrst exons typically
being unmethylated (especially if the gene is expressed)
(Brenet et al. 2011; Edwards et al. 2010) while internal
exons and introns tend to show variable methylation
(Brenet et al. 2011). While the difference between X-linked
male and female gene-body methylation was small, this is
consistent with our previous analysis (Cotton et al. 2009)
and suggests that X-linked male:female gene-body meth-
ylation differences may not be as large as other studies
have suggested.
There are several features of exons and introns which
may explain the observed differences in methylation.
Firstly, although exons typically make up a smaller portion
of genes than introns, exons have a higher GC content and
CpG fraction than any region of the genome other than
promoters (Saxonov et al. 2006). The difference in size
between exons and introns may have also inﬂuenced the
observed methylation as the smaller exons will be more
affected by the surrounding methylation than the larger
introns. CpG density is known to have an effect on the pull
down success of techniques such as MeDIP and while
BATMAN is designed to correct of the effect of CpG
density of pull down efﬁciency (Down et al. 2008), the
methylation differences observed between exons and
introns may in part be due to differences in CpG density.
Exons have been shown to be enriched, compared to
introns, for histone modiﬁcations associated with the
transcription of active genes (Hodges et al. 2009); our data
suggests that X-linked exons maintain their methylation
status regardless of expression while it is introns which
show increased methylation with higher expression sug-
gesting that transcription may affect exons and introns
differently.
The nature of the Xa and Xi provides a unique system to
compare methylation between active and inactive chro-
matin domains. We conclude that the largest difference in
X-linked methylation between males and females is found
at CpG island promoters. Therefore, we proposed that
methylation differences between the sexes could be used to
predict XCI status and found a overall good concordance
with XCI statuses previously determined by expression
analysis. Most genes showed similar methylation, and
therefore the same predicted XCI status across tissues, thus,
our results support that discrepancies between the XCI
statuses we predicted using methylation and those previ-
ously determined may be due to tissue-speciﬁc XCI, as
12% of genes showed methylation patterns suggestive of
tissue-speciﬁc XCI in the four tissues we examined. Using
methylation to predict XCI status would allow for
examination of a gene that is not expressed and would not
require extraction of RNA or restrict studies to females
with clonal XCI. Outside of CpG islands chromosome-
wide methylation analysis revealed differences between
exons and introns suggesting that the effects of transcrip-
tion on gene-body methylation may affect exons and
introns differently.
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